Dabrafenib Plus Trametinib in East Asian Patients With Advanced BRAF V600-Mutant Cutaneous Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Open-Label, Phase IIa Study of Dabrafenib Plus Trametinib in East Asian Patients With Advanced BRAF V600-Mutant Cutaneous Melanoma
Eur. J. Cancer 2020 Aug 01;135(xx)31-38, L Si, X Zhang, SJ Shin, Y Fan, CC Lin, TM Kim, A Dechaphunkul, J Maneechavakajorn, CS Wong, P Ilankumaran, DY Lee, E Gasal, H Li, J GuoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.